Improving critical care by revamping vital signs monitoring

Karachi, June 30, 2021 (PPI-OT):Every second counts when treating a critically-ill patient and their vital signs provide valuable real-time insights into whether a patient’s health is deteriorating, what treatment should be provided or whether treatment is working. Despite their essential role in healthcare; the process of measuring, assessing and evaluating vital signs – such as blood pressure, breaths per minute, heartbeats per minute or pulse, and oxygen saturation or oxygen levels present in blood – is beset by a range of challenges that can potentially harm a patient’s health.

“The problem with vital signs monitoring is three-fold and relates to hardware, software and the efficiency of workflows,” says Dr Naveed Pasha, one of the founding members of a startup, Algos Healthcare, incubated at the University’s i2S incubator, that is working to improve patient outcomes by revamping the entire system underpinning vital signs.

Take the example of 23-year-old Danish Nawaz* who has been rushed to the emergency room in an ambulance after falling off his motorcycle while driving at high speed. The accident led to Danish fracturing his left leg and suffering from internal bleeding near the wound. While in the ambulance, Danish has suffered a drop in blood pressure due to severe bleeding and an acceleration in his pulse which indicate that he needs a blood transfusion. But since most ambulances in Pakistan do not have vital signs monitors the deterioration in these vitals is only picked up in the emergency room, 10 minutes after the accident.

In the emergency room, nurses place a cuff on his arm for blood pressure, an oximeter on his finger, a series of wires near his pulse and arrange another device to measure his temperature. At this point, a still unconscious Danish is surrounded by a range of devices with nurses and doctors hastily observing and recording readings on a file.

Thankfully his condition hasn’t deteriorated, but on average it takes staff a cumbersome five minutes to record vital signs data. These findings then have to be communicated to senior colleagues before treatment can begin. The ER is already a busy place but the multiple wires, bulky devices and people involved in recording and evaluating vital signs makes coordination and communication more difficult than it should be. “It would be so much so much easier if there was a single, wearable device, similar to a smartwatch that could capture all vital signs,” added Dr Naveed.

Once the blood transfusion is complete and Danish’s vitals stabilise, he is shifted to the intensive care unit, ICU, for observation and is later taken for an x-ray on his leg and an MRI to rule out head injuries. While vital signs monitoring is continuous in the ICU, Danish is not connected to vital signs monitors when he is shifted for tests.

This leads to gaps in monitoring occurring when a patient is moved between facilities which mean that doctors have no insights into the patient’s condition during transit. “If there is a delay in administering a test or if a test takes longer than anticipated, then there are large periods of time when the patient’s vitals could have been deteriorating. Healthcare professionals need systems to ensure continuous vital signs monitoring so that complications can be treated in a timely manner,” Dr Naveed notes.

The following day Danish regains consciousness and is shifted to a private room where his wound in bandaged and he is administered painkillers. In the room, his vital signs are measured every four hours. While his vital signs were normal when he was shifted to the room, since then his temperature has risen, his pulse rate has accelerated and his blood pressure has fallen. These could be early warnings signs of sepsis – a common but dangerous infection – or a heart condition.

At Danish’s next check-up, the busy doctor quickly looks over the file with his baseline vital signs and deems the existing readings to be within the normal range. While the nurse communicates that his temperature has increased, the doctor has just been paged about a critically ill patient and has to leave.

On his return, the doctor notices that Danish’s temperature has increased further while his blood pressure readings have also fallen. The doctor calls for intravenous fluids and antibiotics to be administered and orders a series of blood tests. The blood work confirms that Danish has contracted sepsis which will require an extended hospital stay.

Most hospitals lack the software and servers that can enable vital signs data to be stored online for instant access by doctors anywhere in the hospital. The availability of these systems would enable doctors to easily interpret real-time trends about a patient’s health instead of going through handwritten files which only have readings taken at particular intervals.

Dr Naveed says: “Improved access to information can reduce the chance of medical error, reduce the length of hospital stay and lower the risk of readmissions.” Over the past two years, Dr Naveed and his team of doctors and engineers have analysed the strengths and weaknesses in existing vital signs monitoring systems.

They are currently developing a wearable prototype device that seeks to capture all vital signs on a single screen. The device consists of a cuff worn around the wrist, which measures pulse and breathing rate that is connected to a ring on a patient’s index finger via a single wire which measures blood pressure and oxygen saturation. Importantly, this device records data automatically, in real-time. It takes just 30 seconds to capture all vital signs and is being developed to relay data to nearby devices in under a minute.

“We foresee each patient wearing this device throughout their hospital stay thereby enabling uninterrupted monitoring of vital signs,” said Dr Mehdia Nadeem, MBBS ’20 and team lead at Algos Healthcare. “By using bluetooth technology, we hope to transmit this information to nearby devices or a hospital server so that physicians can evaluate the data promptly and conveniently.”

The team notes that a similar vital signs monitoring system has been developed in North America which costs hospitals US $5,000 per device. “The cost of this device is unaffordable for hospitals in low and middle income countries and so we’re looking to develop a system that will be available for under US $300 per device,” Dr Mehdia adds.

Algos Healthcare’s team consists of doctors and software engineers from AKU, Habib University and the National Institute of Cardiovascular Diseases who have been working with mentors at AKU’s i2S incubator over the past two years. “We’ve achieved so many milestones in the development of our project thanks to the connections and expertise that we’ve accessed through i2S,” said Dr Mehdia. “They continue to be an invaluable source of support as we work on perfecting our prototype device.”

For more information, contact:
Media Executive
Department of Public Affairs
Aga Khan University (AKU)
Stadium Road, Karachi
Tel: +92-21-34930051
Fax: +92-21-34934294, +92-21-34932095
Cell: +92-301-8258028
Email: rasool.sarang@aku.edu, public.affairs@aku.edu
Website: www.aku.edu

Roche and AKU Outreach Health Network signs agreement to fight HEP-C

Karachi, June 29, 2021 (PPI-OT): Roche Pakistan Ltd, one of the leading pharmaceutical and diagnostic companies of Pakistan, actively involved in supporting patient’s welfare programs under its continuing Global Commitment to the elimination of Hepatitis C and has agreed to provide in-kind support in proprietary reagents and consumables to the Aga Khan University Outreach Health Network for its Hepatitis-C Elimination Programme. While following the infection control SOPs for COVID-19, the charitable donation ceremony was held on Wednesday, 23 June 2021. Abdul Qayyum, Country Manager, Roche Diagnostics Pakistan and Afghanistan and Shagufta Hassan, CEO, AKU Outreach Health Network signed the agreement.

Through this contribution, the Aga Khan University Outreach Health Network will make high quality and holistic care of Hepatitis-C accessible to patients from low-income households, across Pakistan. Spread across two years, this contribution supports the Aga Khan University Outreach Health Network with its goal of providing free-of cost treatment to 12,000 indigent patients in Karachi, Larkana, Nawabshah, Jacobabad, Lahore, Rawalpindi, Multan, and Peshawar, through its 11 Outreach Medical Centres in three provinces.

“I am delighted that we are able to partner with a prestigious and highly reputable institution like the Aga Khan University Hospital where quality, consistency and unparalleled focus towards patient care are key. Through this partnership, as part of Roche’s Access Program, I am confident that both the Aga Khan University Outreach Health Network and Roche Diagnostics Pakistan will play a critical role in reaching WHO’s 2030 viral hepatitis elimination targets by enabling improved patient management and delivering innovative, high-quality diagnostic solutions where they are needed most.” said Abdul Qayyum, Country Manager, Roche Diagnostics Pakistan, while addressing the room at the ceremony.

“I would like to thank Roche Diagnostics for this generous contribution to the national cause of Hepatitis-C elimination. Today, we are a step closer to defeating this deadly virus. AKU Outreach Health Network will continue to reach out to those in need of compassionate care and provide them with the highest quality standards at their doorsteps.” Commented Shagufta Hassan, CEO, Aga Khan University Outreach Health Network, Pakistan.

“Eliminating Hepatitis-C from Pakistan will prevent nearly 30,000 deaths per year in adults in the prime of their lives and drastically reduce the burden of liver cancer in the country.” said Dr. Saeed Hamid, Professor of Medicine, AKU while stressing upon the importance of eliminating Hepatitis-C in Pakistan.

“Infectious diseases, such as hepatitis, are a challenge and a great threat throughout Asia that cannot be tackled alone. At Roche, we believe that collaboration is key in driving meaningful impact to enhance sustainable healthcare. We are proud of our partnership with the Aga Khan University Outreach Health Network and look forward to providing robust and dependable HCV diagnostic solutions to help manage and achieve the program’s ambitious goal of treating 12,000 underprivileged HCV patients.”
Said Guido Sander, Head of High Growth Markets, and Roche Diagnostics Asia Pacific in a recorded video message.

“I would like to thank Roche Pakistan for partnering with AKU to provide access to quality and holistic treatment to indigent Hepatitis-C patients through AKU’s Outreach Health Network. Each one of us has a role to play in eliminating hepatitis in Pakistan. This initiative is in line with the government’s response, and with our expertise and countrywide outreach capabilities. This initiative is a much-needed step towards a cause that will benefit all of Pakistan. We look forward to continuing to build on our strong ties with Roche in Kenya, where together we are conducting world-class clinical trials to combat COVID-19 related pneumonia, cancer, multiple sclerosis, and of course, for the betterment of Pakistan, to improve the quality of life of those who need it most.” said Firoz Rasul, President Aga Khan University.

Hepatitis-C is a liver infection, caused by the Hepatitis-C Virus. It is often called a “silent killer”, because the infection produces few or no symptoms. Pakistan bears the second highest burden of the disease, comprising at least 5 percent of the total population. While antiviral medicines can cure more than 95% of these patients, access to screening, diagnosis and treatment is low in most parts of the country.

Through the generous support of donors, the Aga Khan University Outreach Health Network’s Hepatitis-C Elimination Programme aims to improve accessibility for Zakat mustehiq and other financially challenged patients. In treating each Hepatitis-C patient, the Aga Khan University Hospital’s Patient Welfare Programme along with Roche Diagnostics and other corporate partners will together bear 75% of the total cost of treatment with the remainder to be provided by generous donors to AKUH or to the Patients’ Behbud Society for AKUH’s Zakat fund and Patient Welfare Programme.

Since the Patient Welfare Programme’s inception, 5.4 million patient visits have been supported thanks to the generosity of our donors, with a total PKR 21 billion disbursed. This has enabled needy patient’s access to quality treatment and care at AKUH hospitals, Medical Centres and Laboratories. With the help and support of individuals and corporations, the Patients’ Behbud Society for AKUH has been able to provide financial assistance of more than PKR 2.08 billion to more than 69,500 Zakat mustehiq patients since its establishment in 2001.

For more information, contact:
Media Executive
Department of Public Affairs
Aga Khan University (AKU)
Stadium Road, Karachi
Tel: +92-21-34930051
Fax: +92-21-34934294, +92-21-34932095
Cell: +92-301-8258028
Email: rasool.sarang@aku.edu, public.affairs@aku.edu
Website: www.aku.edu

AKU and University of Michigan to deepen ties

Karachi, June 19, 2021 (PPI-OT):Aga Khan University and the University of Michigan, U-M, have agreed to deepen their collaboration across a range of academic and scientific initiatives in the fields of medicine and public health. University of Michigan Center for Global Health Equity Director Dr Joseph Kolars and AKU Provost and Vice-President, Academic, Dr Carl Amrhein signed an agreement between the two institutions during a virtual ceremony. The event was also attended by AKU President Firoz Rasul and U-M President Dr Mark Schlissel.

During the event, both universities acknowledged how their shared values would enable them to launch projects that would generate knowledge and create opportunities to expand access to high quality healthcare and education.

“Successful partnerships are based on shared values. And clearly, AKU and Michigan share fundamental values,” said AKU President Firoz Rasul. “We believe in the power of knowledge and the power of collaboration to address the challenges that individuals and families face in their daily lives. If we want to make a real dent in scourges like infant mortality or the growing burden of non-communicable diseases in low-income countries, we need globe-spanning partnerships like the one between AKU and Michigan.”

U-M and AKU have been collaborating on projects since 2019 with an emphasis on research initiatives that use data science to improve health outcomes. Scholars from the two universities noted that the impact of existing and planned joint projects was likely to be greater since AKU and U-M already have experience and expertise in working on common themes such as strengthening health systems, informing policy on health determinants, leveraging technology for health equity, and empowering women.

“A core part of our mission is serving the people of Michigan and the world,” Dr Schlissel said. “International collaboration enables us to pursue unique research opportunities and tackle critical challenges facing our societies in ways that we simply could not do alone. This includes working with global partners who share our core values, which is certainly the case with AKU.”

The U-M is one of the largest public research institutions in the world and enrolls over 64,000 students annually across 3 campuses within the state of Michigan. These students represent 139 countries.

“You’ve really managed to bring out the best in us,” Dr Kolars said. “I’m particularly attracted to the commitment that Aga Khan has made to education and translating new knowledge into action. I’ve always admired your ability to build new bridges, and to really be relevant to the communities that you’re called on to serve .”

The two universities are already collaborating on data science and artificial intelligence projects in East Africa that seek to strengthen local health systems and to raise healthcare standards. In the future, both partners also plan to cooperate and co-create new teaching and scholarly projects, faculty development and student internship initiatives.

“We feel so honoured that you trust us as a valued partner,” said Dr Kolars. “We are excited about how you’ve already energised us and how this process is underway. Thank you again for allowing us to co-create and learn together.”

For more information, contact:
Media Executive
Department of Public Affairs
Aga Khan University (AKU)
Stadium Road, Karachi
Tel: +92-21-34930051
Fax: +92-21-34934294, +92-21-34932095
Cell: +92-301-8258028
Email: rasool.sarang@aku.edu, public.affairs@aku.edu
Website: www.aku.edu

AKU and WHO EMRO join hands to raise LMIC healthcare standards

Karachi, June 17, 2021 (PPI-OT):The Aga Khan University’s Medical College, Pakistan’s faculty collaborated with the World Health Organization’s Regional Office for the Eastern Mediterranean to conduct a comprehensive 10-day course on hospital management for healthcare professionals in low and middle income countries (LMICs).

Most senior officials in hospitals in developing countries tend to be doctors who have been promoted to managerial roles. It is rare for these healthcare professionals to have experience or formal training in how to plan and run the operations of a hospital which hinders efforts to address common issues in the healthcare sector such as operational inefficiencies, poor use of resources and unproductive workflows that impact patients.

Dr Sameen Siddiqi, who is a former WHO Director of Health Systems, and current Chair, Department of Community Health Sciences at AKU Medical College, spearheaded this multilateral collaboration as the Course Advisor. The course received above 400 applications, signifying a large demand for such capacity building trainings in LMICs. Over 40 healthcare professionals working in public and private sector hospitals in Pakistan, Afghanistan, Iran, Somalia and Sudan attended the skills-based online course which included case studies, group projects and expert sessions that spanned key areas such as strategic planning, finance and budgeting, supply chain management, workforce management and disaster preparedness and management.

“You can’t raise healthcare standards without improving the performance of hospitals,” said Dr Bisma Imtiaz, Course Co-Director. “Improving hospital management practices is a proven, low-cost and high-impact method to enhance access to quality healthcare.” Dr Narjis Rizvi was also a Co-Director of the course.

Participants were shown how to evaluate the technical feasibility, cost implications and quality and safety parameters of various proposals to enhance hospital performance. They were challenged with a hospital management case study situated in a relatable low resource setting. The case studies spanned the duration of the course, with participants working in groups to apply skills acquired such as conducting SWOT analyses, conflict resolution, vision and mission statement development, budget planning, application of priority matrices to complex conditions, and much more.

Groups showcased their work during the closing ceremony, leaving course facilitators and directors confident in participants’ abilities to utilise all tools in their own resource constrained hospitals to improve healthcare standards. Course participant Esther Mwadime commented on the case study activity, saying “It really brought us together, it was the epitome of true teamwork in a diverse environment.”

“The WHO remains committed to improving hospital performance in order to achieve universal healthcare goals,” said Dr Ravaghi. “We will continue to pursue this goal through collaborations and partnerships with reputable academic institutes in the region, particularly with AKU, to ensure sustainability of these programmes.” The course contributes to Sustainable Development Goal (SDG) 17 which stands for strong global partnerships and cooperation to best achieve sustainable development in LMICs. The course’s objectives align under target 3C of Goal 3, Good Health and Wellbeing, which call for special efforts to build the capacity of healthcare workforce in developing countries, and contribute to the overall United Nation’s 2030 Agenda for sustainable development.

For more information, contact:
Media Executive
Department of Public Affairs
Aga Khan University (AKU)
Stadium Road, Karachi
Tel: +92-21-34930051
Fax: +92-21-34934294, +92-21-34932095
Cell: +92-301-8258028
Email: rasool.sarang@aku.edu, public.affairs@aku.edu
Website: www.aku.edu